Implementation of the Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA) Plan Disenrollment Reasons Survey (CMS-10316)

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form CMS-10316 Medicare Disenrollee Survey, Medicare Advantage (MA-PD and MA-Only)	Form	Modified	Available
Form CMS-10316 Medicare Disenrollee Survey - MA-PD	Form	Removed	Available
Form CMS-10316 Medicare Disenrollee Survey, Stand Alone Prescription Drug Plan (PDP) Version	Form	Modified	Available
Supporting statement A_CMS-10316_Disenrollment Reasons Survey_CLEAN V2.docx	Supporting Statement A	Uploaded 2020-12-09	Available
supporting statement B_disenrollment reasons survey_clean_lp_02.11.2020.docx	Supporting Statement B	Uploaded 2020-03-23	Available
CMS Response to Public Comments_02_04_2020_CLEAN.docx	Supplementary Document	Uploaded 2020-03-23	Available
PDP Disenrollment Survey crosswalk_OMB__508FINAL.pdf	Supplementary Document	Uploaded 2020-03-23	Available
MA-ONLY Disenrollment Survey crosswalk_OMB__508FINAL.pdf	Supplementary Document	Uploaded 2020-03-23	Available
MA_PD Disenrollment Survey crosswalk_OMB_508FINAL.pdf	Supplementary Document	Uploaded 2020-03-23	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
207675	Medicare Disenrollee Survey, Medicare Advantage (MA-PD and MA-Only)	Form	Modified
194738	Medicare Disenrollee Survey - MA-PD	Form	Removed
194737	Medicare Disenrollee Survey, Stand Alone Prescription Drug Plan (PDP) Version	Form	Modified

ICR Details

OMB Control No: 0938-1113	ICR Reference No: 202003-0938-016
Status: Active	Previous ICR Reference No: 201607-0938-007
Agency/Subagency: HHS/CMS	Agency Tracking No: CM-CPC
Title: Implementation of the Medicare Prescription Drug Plan (PDP) and Medicare Advantage (MA) Plan Disenrollment Reasons Survey (CMS-10316)
Type of Information Collection: Revision of a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved with change	Conclusion Date: 12/10/2020
	Date Received in OIRA: 03/24/2020
Terms of Clearance: Previous terms continue: When four years of data are available, CMS will evaluate the within-plan temporal variability in quality scores available to consumers and adjust the frequency of the data collection accordingly. If there is very little change in the quality scores across time, CMS will consider collecting the information less frequently and present a report to OMB.

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	12/31/2023	36 Months From Approved	12/31/2020
Responses	43,872	0	56,972
Time Burden (Hours)	9,354	0	12,754
Cost Burden (Dollars)	0	0	0

---

Abstract: This information collection will survey disenrollees from Medicare Prescription Drug Plans (PDPs) and Medicare Advantage Prescription Drug Plans (MA-PDs). The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) provides a requirement to collect and report performance data for Part D prescription drug plans. Specifically, the MMA under Sec. 1860D-4 (Beneficiary Protections for Qualified Prescription Drug Coverage) requires CMS to conduct consumer satisfaction surveys regarding PDPs and MA-PDs - pursuant to section 1860D-4(d). This data collection complements the satisfaction data collected through the Medicare CAHPS Survey by providing dissatisfaction data in the form of reasons for disenrollment from PDPs and MA-PDs.

---

Authorizing Statute(s): Statute at Large: 1 Stat. 1860 Name of Statute: null
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	84 FR 55966	10/18/2019
30-day Notice:	Federal Register Citation:	Citation Date:
	85 FR 16634	03/24/2020
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

table that charts list of burden

IC Title	Form No.	Form Name
Medicare Disenrollee Survey, Stand Alone Prescription Drug Plan (PDP) Version	CMS-10316	Medicare Disenrollee Survey Prescriptopn Drug Plan
Medicare Disenrollee Survey, Medicare Advantage (MA-PD and MA-Only)	CMS-10316, CMS-10316	MA PD Survey ,   MA Only Survey
Medicare Disenrollee Survey - MA-PD	CMS-10316	Medicare Disenrollee Survey - MA PD

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	43,872	56,972	0	0	-13,100	0
Annual Time Burden (Hours)	9,354	12,754	0	0	-3,400	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The proposed revisions reduce our estimated completion time per survey from 12 to 11 minutes for PDP survey responses, and from 14 to 13 minutes for MA responses. On an annualized basis, the estimate of respondent burden is also reduced from the estimate provided in our 2017 OMB application due to a reduction in response rates from ~40% (2017 OMB application assumption) to ~30% (based on observed response rates for the survey in years 2016 and 2017). Total burden has decreased from 12,754 to 9,354.

---

Annual Cost to Federal Government: $1,717,335

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 03/24/2020

---